TrialCirculation2025

Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial.

Samer Al Said et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.